Effentora

Country: Evrópusambandið

Tungumál: enska

Heimild: EMA (European Medicines Agency)

Kauptu það núna

Vara einkenni Vara einkenni (SPC)
04-04-2024
Opinber matsskýrsla Opinber matsskýrsla (PAR)
14-04-2014

Virkt innihaldsefni:

fentanyl

Fáanlegur frá:

Teva B.V.

ATC númer:

N02AB03

INN (Alþjóðlegt nafn):

fentanyl

Meðferðarhópur:

Analgesics

Lækningarsvæði:

Pain; Cancer

Ábendingar:

Effentora is indicated for the treatment of breakthrough pain (BTP) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain. BTP is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain. Patients receiving maintenance opioid therapy are those who are taking at least 60 mg of oral morphine daily, at least 25 micrograms of transdermal fentanyl per hour, at least 30 mg of oxycodone daily, at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid for a week or longer. ,

Vörulýsing:

Revision: 28

Leyfisstaða:

Authorised

Leyfisdagur:

2008-04-04

Upplýsingar fylgiseðill

                                44
B. PACKAGE LEAFLET
45
PACKAGE LEAFLET: INFORMATION FOR THE USER
EFFENTORA 100 MICROGRAMS BUCCAL TABLETS
EFFENTORA 200 MICROGRAMS BUCCAL TABLETS
EFFENTORA 400 MICROGRAMS BUCCAL TABLETS
EFFENTORA 600 MICROGRAMS BUCCAL TABLETS
EFFENTORA 800 MICROGRAMS BUCCAL TABLETS
Fentanyl
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Effentora is and what it is used for
2.
What you need to knowbefore you use Effentora
3.
How to use Effentora
4.
Possible side effects
5.
How to store Effentora
6.
Contents of the pack and other information
1.
WHAT EFFENTORA IS AND WHAT IT IS USED FOR
The active substance of Effentora is fentanyl citrate. Effentora is a
pain-relieving medicine known as
an opioid, which is used to treat breakthrough pain in adult patients
with cancer who are already taking
other opioid pain medicines for their persistent (around-the-clock)
cancer pain.
Breakthrough pain is additional, sudden pain that occurs in spite of
you having taken your usual opioid
pain-relieving medicines.
2.
WHAT YOU NEED TO KNOW BEFORE YOU USE EFFENTORA
DO NOT USE EFFENTORA:
•
If you are not regularly using a prescribed opioid medicine (e.g
codeine, fentanyl, hydromorphone,
morphine, oxycodone, pethidine), every day on a regular schedule, for
at least a week, to control
your persistent pain. If you have not been using these medicines you MUST NOT
use Effentora,
because it may increase the risk that breathing could become
dangerously slow and/or shallow, or
even stop.
•
If you are allergic to fentanyl or any of the ot
                                
                                Lestu allt skjalið
                                
                            

Vara einkenni

                                1
_ _
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Effentora 100 micrograms buccal tablets
Effentora 200 micrograms buccal tablets
Effentora 400 micrograms buccal tablets
Effentora 600 micrograms buccal tablets
Effentora 800 micrograms buccal tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Effentora 100 micrograms buccal tablets
Each buccal tablet contains 100 micrograms fentanyl (as citrate).
Excipient with known effect: Each tablet contains 10 mg of sodium.
Effentora 200 micrograms buccal tablets
Each buccal tablet contains 200 micrograms fentanyl (as citrate).
Excipient with known effect: Each tablet contains 20 mg of sodium.
Effentora 400 micrograms buccal tablets
Each buccal tablet contains 400 micrograms fentanyl (as citrate).
Excipient with known effect: Each tablet contains 20 mg of sodium.
Effentora 600 micrograms buccal tablets
Each buccal tablet contains 600 micrograms fentanyl (as citrate).
Excipient with known effect: Each tablet contains 20 mg of sodium.
Effentora 800 micrograms buccal tablets
Each buccal tablet contains 800 micrograms fentanyl (as citrate).
Excipient with known effect: Each tablet contains 20 mg of sodium.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Buccal tablet.
Effentora 100 micrograms buccal tablets
Flat-faced, white, round bevelled-edge tablet, embossed on one side
with a “C” and on the other side
with “1”.
Effentora 200 micrograms buccal tablets
Flat-faced, white, round bevelled-edge tablet, embossed on one side
with a “C” and on the other side
with “2”.
Effentora 400 micrograms buccal tablets
Flat-faced, white, round bevelled-edge tablet, embossed on one side
with a “C” and on the other side
with “4”.
Effentora 600 micrograms buccal tablets
Flat-faced, white, round bevelled-edge tablet, embossed on one side
with a “C” and on the other side
with “6”.
3
Effentora 800 micrograms buccal tablets
Flat-faced, white, round bevelled-edge tablet, embossed on one side
with a “C” and on
                                
                                Lestu allt skjalið
                                
                            

Skjöl á öðrum tungumálum

Upplýsingar fylgiseðill Upplýsingar fylgiseðill búlgarska 04-04-2024
Vara einkenni Vara einkenni búlgarska 04-04-2024
Opinber matsskýrsla Opinber matsskýrsla búlgarska 14-04-2014
Upplýsingar fylgiseðill Upplýsingar fylgiseðill spænska 04-04-2024
Vara einkenni Vara einkenni spænska 04-04-2024
Opinber matsskýrsla Opinber matsskýrsla spænska 14-04-2014
Upplýsingar fylgiseðill Upplýsingar fylgiseðill tékkneska 04-04-2024
Vara einkenni Vara einkenni tékkneska 04-04-2024
Opinber matsskýrsla Opinber matsskýrsla tékkneska 14-04-2014
Upplýsingar fylgiseðill Upplýsingar fylgiseðill danska 04-04-2024
Vara einkenni Vara einkenni danska 04-04-2024
Opinber matsskýrsla Opinber matsskýrsla danska 14-04-2014
Upplýsingar fylgiseðill Upplýsingar fylgiseðill þýska 04-04-2024
Vara einkenni Vara einkenni þýska 04-04-2024
Opinber matsskýrsla Opinber matsskýrsla þýska 14-04-2014
Upplýsingar fylgiseðill Upplýsingar fylgiseðill eistneska 04-04-2024
Vara einkenni Vara einkenni eistneska 04-04-2024
Opinber matsskýrsla Opinber matsskýrsla eistneska 14-04-2014
Upplýsingar fylgiseðill Upplýsingar fylgiseðill gríska 04-04-2024
Vara einkenni Vara einkenni gríska 04-04-2024
Opinber matsskýrsla Opinber matsskýrsla gríska 14-04-2014
Upplýsingar fylgiseðill Upplýsingar fylgiseðill franska 04-04-2024
Vara einkenni Vara einkenni franska 04-04-2024
Opinber matsskýrsla Opinber matsskýrsla franska 14-04-2014
Upplýsingar fylgiseðill Upplýsingar fylgiseðill ítalska 04-04-2024
Vara einkenni Vara einkenni ítalska 04-04-2024
Opinber matsskýrsla Opinber matsskýrsla ítalska 14-04-2014
Upplýsingar fylgiseðill Upplýsingar fylgiseðill lettneska 04-04-2024
Vara einkenni Vara einkenni lettneska 04-04-2024
Opinber matsskýrsla Opinber matsskýrsla lettneska 14-04-2014
Upplýsingar fylgiseðill Upplýsingar fylgiseðill litháíska 04-04-2024
Vara einkenni Vara einkenni litháíska 04-04-2024
Opinber matsskýrsla Opinber matsskýrsla litháíska 14-04-2014
Upplýsingar fylgiseðill Upplýsingar fylgiseðill ungverska 04-04-2024
Vara einkenni Vara einkenni ungverska 04-04-2024
Opinber matsskýrsla Opinber matsskýrsla ungverska 14-04-2014
Upplýsingar fylgiseðill Upplýsingar fylgiseðill maltneska 04-04-2024
Vara einkenni Vara einkenni maltneska 04-04-2024
Opinber matsskýrsla Opinber matsskýrsla maltneska 14-04-2014
Upplýsingar fylgiseðill Upplýsingar fylgiseðill hollenska 04-04-2024
Vara einkenni Vara einkenni hollenska 04-04-2024
Opinber matsskýrsla Opinber matsskýrsla hollenska 14-04-2014
Upplýsingar fylgiseðill Upplýsingar fylgiseðill pólska 04-04-2024
Vara einkenni Vara einkenni pólska 04-04-2024
Opinber matsskýrsla Opinber matsskýrsla pólska 14-04-2014
Upplýsingar fylgiseðill Upplýsingar fylgiseðill portúgalska 04-04-2024
Vara einkenni Vara einkenni portúgalska 04-04-2024
Opinber matsskýrsla Opinber matsskýrsla portúgalska 14-04-2014
Upplýsingar fylgiseðill Upplýsingar fylgiseðill rúmenska 04-04-2024
Vara einkenni Vara einkenni rúmenska 04-04-2024
Opinber matsskýrsla Opinber matsskýrsla rúmenska 14-04-2014
Upplýsingar fylgiseðill Upplýsingar fylgiseðill slóvakíska 04-04-2024
Vara einkenni Vara einkenni slóvakíska 04-04-2024
Opinber matsskýrsla Opinber matsskýrsla slóvakíska 14-04-2014
Upplýsingar fylgiseðill Upplýsingar fylgiseðill slóvenska 04-04-2024
Vara einkenni Vara einkenni slóvenska 04-04-2024
Opinber matsskýrsla Opinber matsskýrsla slóvenska 14-04-2014
Upplýsingar fylgiseðill Upplýsingar fylgiseðill finnska 04-04-2024
Vara einkenni Vara einkenni finnska 04-04-2024
Opinber matsskýrsla Opinber matsskýrsla finnska 14-04-2014
Upplýsingar fylgiseðill Upplýsingar fylgiseðill sænska 04-04-2024
Vara einkenni Vara einkenni sænska 04-04-2024
Opinber matsskýrsla Opinber matsskýrsla sænska 14-04-2014
Upplýsingar fylgiseðill Upplýsingar fylgiseðill norska 04-04-2024
Vara einkenni Vara einkenni norska 04-04-2024
Upplýsingar fylgiseðill Upplýsingar fylgiseðill íslenska 04-04-2024
Vara einkenni Vara einkenni íslenska 04-04-2024
Upplýsingar fylgiseðill Upplýsingar fylgiseðill króatíska 04-04-2024
Vara einkenni Vara einkenni króatíska 04-04-2024
Opinber matsskýrsla Opinber matsskýrsla króatíska 14-04-2014

Leitaðu viðvaranir sem tengjast þessari vöru

Skoða skjalasögu